In addition, genetic variation in the androgen receptor (AR) gene has been correlated with COVID-19 disease severity [9]. Taken together, there is sufficient evidence to suggest that antiandrogen drugs may be a promising treatment for COVID-19. This evidence concerns the gene AR and COVID-19.